Phenanthrene and dihydrophenanthrene derivatives from Vanda curvifolia with cytotoxic activity against glioblastoma cells
Medicine in Drug Discovery · 2026-08 · 31 · 100264
DOI: 10.1016/j.medidd.2026.100264 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medicine in Drug Discovery, 2026-08. Verfasst von Sanith Sri Jayashan und 6 weiteren Autor:innen. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Chulalongkorn University, U.S. Department of Agriculture.
Abstract (Originalsprache)
Glioblastoma remains one of the most lethal and therapeutically intractable primary brain malignancies, with a critical need for novel therapeutic discoveries. Phenanthrenes and dihydrophenanthrenes, gaining attention for their cytotoxic and antiproliferative activities, represent a promising yet underexplored chemical space for glioblastoma drug discovery. Phytochemical investigation of Vanda curvifolia , a species of phenanthrene-rich family Orchidaceae, afforded ten previously undescribed phenanthrene and dihydrophenanthrene constituents, designated vandafolin A –J ( 1−10 ), together with twelve known compounds. Structures were elucidated by NMR and HR-ESI-MS, with absolute configurations assigned by ECD spectroscopy and optical rotation measurements supported by TDDFT calculations. Vandafolin A, B, G, and H exhibited moderate cytotoxicity against U-87 MG glioblastoma cells, while vandafolin A, G, and H further demonstrated moderate antiproliferative activity. Vandafolin A induced G0/G1 cell cycle arrest, while vandafolin G and H induced apoptosis in U-87 MG glioblastoma cells, as determined by propidium iodide (PI) and Annexin V/PI staining flow cytometry, respectively. These results identified vandafolin A, G, and H as preliminary cytotoxic hits against glioblastoma cells, warranting further mechanistic and structural investigation.
Förderung
- Chulalongkorn University
- U.S. Department of Agriculture
Zitieren
APA
Jayashan, S. S., Pengdee, C., Naini, A. A., Jungsuttiwong, S., Nalinratana, N., Sritularak, B., & Sukrong, S. (2026). Phenanthrene and dihydrophenanthrene derivatives from Vanda curvifolia with cytotoxic activity against glioblastoma cells. Medicine in Drug Discovery, 31, 100264. https://doi.org/10.1016/j.medidd.2026.100264
Vancouver
Jayashan SS, Pengdee C, Naini AA, Jungsuttiwong S, Nalinratana N, Sritularak B, et al. Phenanthrene and dihydrophenanthrene derivatives from Vanda curvifolia with cytotoxic activity against glioblastoma cells. Medicine in Drug Discovery. 2026;31:100264. doi:10.1016/j.medidd.2026.100264
BibTeX
@article{Jayashan2026,
author = {Jayashan, Sanith Sri and Pengdee, Chattarika and Naini, Al Arofatus and Jungsuttiwong, Siriporn and Nalinratana, Nonthaneth and Sritularak, Boonchoo and Sukrong, Suchada},
title = {Phenanthrene and dihydrophenanthrene derivatives from Vanda curvifolia with cytotoxic activity against glioblastoma cells},
journal = {Medicine in Drug Discovery},
year = {2026},
volume = {31},
pages = {100264},
doi = {10.1016/j.medidd.2026.100264}
}
EUVIMED